These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2158901)

  • 1. Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites.
    Vannucchi S; Pasquali F; Fiorelli G; Bianchini P; Ruggiero M
    FEBS Lett; 1990 Apr; 263(1):137-41. PubMed ID: 2158901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover.
    Cavari S; Fiorelli G; Vannucchi S
    Br J Pharmacol; 1994 Sep; 113(1):254-60. PubMed ID: 7812618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of BC3H-1 cell growth by heparin is related to decreased mitogenic signalling.
    Vannucchi S; Pasquali F; Chiarugi VP; Ruggiero M
    Biochem Biophys Res Commun; 1990 Jul; 170(1):89-95. PubMed ID: 2164814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.
    Patel MK; Refson JS; Schachter M; Hughes AD
    Br J Pharmacol; 1999 May; 127(2):361-8. PubMed ID: 10385234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin inhibits A431 cell growth independently of serum and EGF mitogenic signalling.
    Vannucchi S; Pasquali F; Chiarugi VP; Ruggiero M
    FEBS Lett; 1991 Apr; 281(1-2):141-4. PubMed ID: 2015884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and heparan sulfate binding sites on B-16 melanoma cells.
    Biswas C
    J Cell Physiol; 1988 Jul; 136(1):147-53. PubMed ID: 2840440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
    Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
    Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.
    Luster AD; Greenberg SM; Leder P
    J Exp Med; 1995 Jul; 182(1):219-31. PubMed ID: 7790818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: cell-surface heparin receptors of promastigotes are recruited from an internal pool after trypsinization.
    Butcher BA; Shome K; Estes LW; Choay J; Petitou M; Sie P; Glew RH
    Exp Parasitol; 1990 Jul; 71(1):49-59. PubMed ID: 2162300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin inhibits inositol trisphosphate-induced calcium release from permeabilized rat liver cells.
    Hill TD; Berggren PO; Boynton AL
    Biochem Biophys Res Commun; 1987 Dec; 149(3):897-901. PubMed ID: 2827657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
    Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
    Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of externally-disposed heparin/heparan sulfate binding sites by uterine epithelial cells.
    Wilson O; Jacobs AL; Stewart S; Carson DD
    J Cell Physiol; 1990 Apr; 143(1):60-7. PubMed ID: 2138625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans.
    Kilfeather SA; Tagoe S; Perez AC; Okona-Mensa K; Matin R; Page CP
    Br J Pharmacol; 1995 Apr; 114(7):1442-6. PubMed ID: 7541692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition.
    Esteban Bertolesi G; Lauría de Cidre L; Sacerdote de Lustig E; Eiján AM
    Cancer Lett; 1995 Apr; 90(2):123-31. PubMed ID: 7736447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of the ability of follicular fluid glycosaminoglycans and chemically desulfated heparin to compete for heparin-binding sites on granulosa cells.
    Bellin ME; Wentworth BC; Ax RL
    Biol Reprod; 1987 Sep; 37(2):293-300. PubMed ID: 2823919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of [3H]heparin to human carcinoma SW-13 and other mammalian cells.
    Halper J
    Exp Cell Res; 1990 Apr; 187(2):324-7. PubMed ID: 2156720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
    Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor.
    Kimura K; Matsubara H; Sogoh S; Kita Y; Sakata T; Nishitani Y; Watanabe S; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2618-24. PubMed ID: 1901881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.